PFBT
MRTX

Parkside Financial Bank & Trust’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-65
Closed -$3.82K – 2116
2023
Q4 		$3.82K Sell
65
-66
-50% -$3.71K ﹤0.01% 1377
2023
Q3 		$5.71K Buy
+131
New +$4.68K ﹤0.01% 1316
2023
Q2 		– Sell
-47
Closed -$1.75K – 2116
2023
Q1 		$1.75K Buy
47
+40
+571% +$1.8K ﹤0.01% 1737
2022
Q4 		$317 Sell
7
-11
-61% -$712 ﹤0.01% 1941
2022
Q3 		$1K Buy
18
+11
+157% +$814 ﹤0.01% 1767
2022
Q2 		$0 Sell
7
-36
-84% -$2.29K ﹤0.01% 1990
2022
Q1 		$4K Buy
+43
New +$4.4K ﹤0.01% 1441
2021
Q4 		– Sell
-35
Closed -$7K – 1946
2021
Q3 		$7K Buy
35
+4
+13% +$644 ﹤0.01% 1125
2021
Q2 		$5K Buy
+31
New +$4.98K ﹤0.01% 1274

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Parkside Financial Bank & Trust's MRTX Position: Q1 2024 in Review

Parkside Financial Bank & Trust sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 65 shares — an estimated $3.82K sold.

Parkside Financial Bank & Trust first reported a position in MRTX in Q2 2021 and held it in 9 quarters. The position peaked at $7K in Q3 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Parkside Financial Bank & Trust reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 65 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $3.82K.
  • Parkside Financial Bank & Trust first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
  • Parkside Financial Bank & Trust's Mirati Therapeutics, Inc. Common Stock position peaked at $7K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2024, filed 1 May 2024.